Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5836 USD | +11.38% | +3.13% | -44.93% |
03-21 | Transcript : Ensysce Biosciences, Inc., Q4 2023 Earnings Call, Mar 21, 2024 | |
03-15 | Ensysce Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.93% | 3.97M | |
+27.14% | 44.96B | |
+0.10% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.19% | 26.08B | |
-21.07% | 19.03B | |
+6.42% | 12.75B | |
+28.75% | 12.06B | |
-3.71% | 11.75B |
- Stock Market
- Equities
- ENSC Stock
- News Ensysce Biosciences, Inc.
- Lake Street Initiates Coverage on Ensysce Biosciences With Buy Rating, $4 Price Target